INR 16.0
(-0.62%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -236.4 Million | 735.6 Million | 1 Billion | -147.5 Million | 621.2 Million | 3.87 Billion |
Net Income | -158.8 Million | -387.4 Million | 257.4 Million | -1.94 Billion | -727.8 Million | -1.26 Billion |
Depreciation & Amortization | 5.4 Million | 5.8 Million | 14.7 Million | 42.7 Million | 181.3 Million | 219.4 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 42.6 Million | 1.16 Billion | 1 Billion | 821.5 Million | 1.51 Billion | 3.7 Billion |
Other non-cash items | -197.2 Million | -43 Million | -270.7 Million | 935.8 Million | -352 Million | 1.21 Billion |
Investing Cash Flow | 178.6 Million | -152 Million | 207.8 Million | 204.4 Million | 3.93 Billion | 1.28 Billion |
Investments in PPE | -1.9 Million | -4.4 Million | -2 Million | -4.2 Million | -11.9 Million | -100.7 Million |
Acquisitions | 100 Thousand | 336.9 Million | 158 Million | -500 Thousand | 2.44 Billion | 146.9 Million |
Investment purchases | -1.61 Billion | -4.03 Billion | -1.36 Billion | 58.2 Million | 355.4 Million | -629.3 Million |
Sales/Maturities of investments | 1.78 Billion | 3.47 Billion | - | 160.3 Million | 1.28 Billion | 1.25 Billion |
Other Investing Activities | 11.8 Million | 71.9 Million | 1.41 Billion | -9.4 Million | -151.4 Million | 613.1 Million |
Financing Cash Flow | -3.7 Million | -618.8 Million | -1.38 Billion | -221.7 Million | -4.9 Billion | -4.77 Billion |
Debt repayment | -3.55 Billion | -4.14 Billion | -1.23 Billion | -17.49 Billion | -21.94 Billion | -16.33 Billion |
Dividends payments | - | - | - | -4.7 Million | -1.2 Million | -5 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -3.7 Million | 3.52 Billion | -154 Million | 17.27 Billion | 17.04 Billion | 11.56 Billion |
Accounts receivables | 82.2 Million | -189.4 Million | 533.4 Million | 975.1 Million | 1.89 Billion | 7.36 Billion |
Accounts payables | - | 189.4 Million | -533.4 Million | -975.1 Million | -1.89 Billion | -3.91 Billion |
Inventory | 200 Thousand | 1.2 Million | 23.3 Million | 250.7 Million | 676 Million | 2.18 Billion |
Other working capital | -39.8 Million | 1.15 Billion | 982.3 Million | 570.8 Million | 843.7 Million | -1.92 Billion |
Cash at beginning of period | 264.7 Million | 218.8 Million | 100 Thousand | 552.6 Million | 904.2 Million | 1.15 Billion |
Cash at end of period | 1.31 Billion | 197.5 Million | 218.8 Million | 388.2 Million | 552.6 Million | 1.54 Billion |
Capital Expenditure | -1.9 Million | -4.4 Million | -2 Million | -4.2 Million | -11.9 Million | -100.7 Million |
Effect of forex changes on cash | 1 Million | 13.9 Million | 390.2 Million | 500 Thousand | -3.4 Million | -1.4 Million |
Net cash flow / Change in cash | 1.05 Billion | -21.3 Million | 218.7 Million | -164.4 Million | -351.6 Million | 384.3 Million |
Free Cash Flow | -238.3 Million | 731.2 Million | 1 Billion | -151.7 Million | 609.3 Million | 3.77 Billion |
Breakdown | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -41.3 Million | -158.8 Million | -55.23 Million | -93 Million | 48.4 Million | -58.9 Million |
Depreciation & Amortization | - | 5.4 Million | - | 1.4 Million | 1.4 Million | 1.4 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | 42.6 Million | - | - | - | - |
Other non-cash items | 41.3 Million | -197.2 Million | 55.23 Million | 93 Million | -48.4 Million | 58.9 Million |
Investing Cash Flow | - | 178.6 Million | - | - | - | - |
Investments in PPE | - | -1.9 Million | - | - | - | - |
Acquisitions | - | 100 Thousand | - | - | - | - |
Investment purchases | - | -1.61 Billion | - | - | - | - |
Sales/Maturities of investments | - | 1.78 Billion | - | - | - | - |
Other Investing Activities | - | 11.8 Million | - | - | - | - |
Financing Cash Flow | - | -3.7 Million | - | - | - | - |
Debt repayment | - | -3.55 Billion | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | -3.7 Million | - | - | - | - |
Accounts receivables | - | 82.2 Million | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | 200 Thousand | - | - | - | - |
Other working capital | - | -39.8 Million | - | - | - | - |
Cash at beginning of period | - | 264.7 Million | - | 1.94 Billion | 1.94 Billion | 264.7 Million |
Cash at end of period | - | 1.31 Billion | - | 1.95 Billion | 1.94 Billion | 267.5 Million |
Capital Expenditure | - | -1.9 Million | - | - | - | - |
Effect of forex changes on cash | - | 1 Million | - | - | - | - |
Net cash flow / Change in cash | - | 1.05 Billion | - | 2.8 Million | 2.8 Million | 2.8 Million |
Free Cash Flow | - | -238.3 Million | - | 2.8 Million | 2.8 Million | 2.8 Million |
IGPL
ACCELYA
7095
MAXHEALTH
LTHIF
NGKIF